ENHANCED LIVER FIBROSIS ELF PANEL Test
Test Name: ENHANCED LIVER FIBROSIS ELF PANEL Test
Components:
- Hyaluronic acid (HA)
- Amino terminal Propeptide type III Procollagen (PIIINP)
- Tissue inhibitor Metalloproteinase 1 (TIMP-1)
- ELF score
Price: 1050.0 AED
Sample Condition: 3 mL (1.5 mL min.) serum from 1 SST. Ship refrigerated or frozen. Overnight fasting is mandatory.
Report Delivery: SampleMon / Thu by 4 pm; Report Next day
Method: Chemiluminescent Microparticle Immunoassay
Test type: Disorders of Liver
Doctor: Gastroenterologist, Physician
Test Department:
Pre Test Information: Overnight fasting is mandatory.
Test Details:
The Enhanced Liver Fibrosis (ELF) Panel test is a blood test that is used to assess the severity of liver fibrosis. Liver fibrosis is the scarring of the liver tissue that occurs as a result of chronic liver disease. The ELF Panel test measures three specific biomarkers in the blood: hyaluronic acid (HA), tissue inhibitor of metalloproteinase 1 (TIMP-1), and amino-terminal propeptide of type III collagen (PIIINP). These biomarkers are associated with the production and degradation of liver fibrosis. By measuring the levels of these biomarkers, the ELF Panel test can provide a numerical score that indicates the extent of liver fibrosis. The higher the score, the more severe the fibrosis.
The ELF Panel test is often used as a non-invasive alternative to liver biopsy, which is the gold standard for assessing liver fibrosis. Liver biopsy involves the removal of a small sample of liver tissue for examination under a microscope. However, liver biopsy is an invasive procedure that carries some risks and may not be suitable for all patients.
The ELF Panel test can be used to monitor the progression of liver fibrosis over time and to guide treatment decisions. It is particularly useful in patients with chronic liver diseases such as hepatitis B, hepatitis C, and non-alcoholic fatty liver disease (NAFLD).
Overall, the ELF Panel test is a valuable tool for assessing liver fibrosis non-invasively and can provide important information for the management of patients with chronic liver diseases.
Test Name | ENHANCED LIVER FIBROSIS ELF PANEL Test |
---|---|
Components | *Hyaluronic acid (HA)*Amino terminal Propeptide type III Procollagen (PIIINP) *Tissue inhibitor Metalloproteinase 1 (TIMP-1)*ELF score |
Price | 1050.0 AED |
Sample Condition | 3 mL (1.5 mL min.) serum from 1 SST. Ship refrigerated or frozen. Overnight fasting is mandatory. |
Report Delivery | SampleMon / Thu by 4 pm; Report Next day |
Method | Chemiluminescent Microparticle Immunoassay |
Test type | Disorders of Liver |
Doctor | Gastroenterologist, Physician |
Test Department: | |
Pre Test Information | Overnight fasting is mandatory. |
Test Details | The Enhanced Liver Fibrosis (ELF) Panel test is a blood test that is used to assess the severity of liver fibrosis. Liver fibrosis is the scarring of the liver tissue that occurs as a result of chronic liver disease. The ELF Panel test measures three specific biomarkers in the blood: hyaluronic acid (HA), tissue inhibitor of metalloproteinase 1 (TIMP-1), and amino-terminal propeptide of type III collagen (PIIINP). These biomarkers are associated with the production and degradation of liver fibrosis. By measuring the levels of these biomarkers, the ELF Panel test can provide a numerical score that indicates the extent of liver fibrosis. The higher the score, the more severe the fibrosis. The ELF Panel test is often used as a non-invasive alternative to liver biopsy, which is the gold standard for assessing liver fibrosis. Liver biopsy involves the removal of a small sample of liver tissue for examination under a microscope. However, liver biopsy is an invasive procedure that carries some risks and may not be suitable for all patients. The ELF Panel test can be used to monitor the progression of liver fibrosis over time and to guide treatment decisions. It is particularly useful in patients with chronic liver diseases such as hepatitis B, hepatitis C, and non-alcoholic fatty liver disease (NAFLD). Overall, the ELF Panel test is a valuable tool for assessing liver fibrosis non-invasively and can provide important information for the management of patients with chronic liver diseases. |